Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2019 | HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. | Ogawa, E; Toyoda, H; Iio, E; Jun, DW; Huang, CF; Enomoto, M; Hsu, YC; Haga, H; Iwane, S; Wong, G; Lee, DH; Tada, T; Liu, CH; Chuang, WL; Hayashi, J; Cheung, R; Yasuda, S; Tseng, CH; Takahashi, H; Tran, S; Yeo, YH; Henry, L; Barnett, SD; Nomura, H; Nakamuta, M; Dai, CY; Huang, JF; Yang, HI ; Lee, MH; Jung Jun, M; Kao, JH; Eguchi, Y; Ueno, Y; Tamori, A; Furusyo, N; Yu, ML; Tanaka, Y; Nguyen, MH; Ahn, SB; Azuma, K; Dohmen, K; Yoon Jeong, J; Jung, JH; Kajiwara, E; Kato, M; Kawano, A; Koyanagi, T; Ooho, A; Park, SH; Satoh, T; Shimoda, S; Song, DS; Takahashi, K; Yeh, ML; Yoon, EL | Clinical Infectious Diseases, ciz1160 | | | |
1993 | Hemostatic factors and blood lipids in young Buddhist vegetarians and omnivores. | Pan, WH; Chin, CJ; Sheu, CT; Lee, MH | The American journal of clinical nutrition 58(3), 354-359 | | | |
2017 | Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study | Lai, TS; Lee, MH; Yang, HI; You, SL; Lu, SN; Wang, LY; Yuan, Y; L'Italien, G; Chien, KL; Chen, CJ | Hepatology (Baltimore, Md.) 66(3), 784-793 | | | |
2010 | Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: Long-term predictors from a community-based cohort study | Lee, MH; Yang, HI; Lu, SN; Jen, CL; Yeh, SH; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Chen, WJ; Chen, CJ | J Clin Oncol 28:4587-4593 | | | |
2015 | Hepatocellular carcinoma risk scores: ready to use in 2015? | Chen, CJ; Lee, MH; Liu, J; Yang, HI | Hepat Oncol 2, 1-4 | | | |
2017 | High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease | Lai, TS; Lee, MH; Yang, HI; You, SL; Lu, SN; Wang, LY; Yuan, Y; L'Italien, G; Chien, KL; Chen, CJ | Kidney international 92(3), 703-709 | | | |
2021 | HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma. | Liu, Z; Huang, CJ; Huang, YH; Pan, MH; Lee, MH; Yu, KJ; Pfeiffer, RM; Viard, M; Yuki, Y; Gao, X; Carrington, M; Chen, CJ ; Hildesheim, A; Yang, HI | The Journal of Infectious Diseases 224(10), 1796-1805 | | | |
2018 | Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study. | Lee, MH; Huang, YH; Chen, HY ; Khor, SS; Chang, YH; Lin, YJ; Jen, CL; Lu, SN; Yang, HI; Nishida, N; Sugiyama, M; Mizokami, M; Yuan, Y; L'Italien, G; Tokunaga, K; Chen, CJ | Hepatology (Baltimore, Md.) 67(2), 651-661 | | | |
2021 | Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals | Koshiol, J; Argirion, I; Liu, Z; Kim, Lam, T; O'Brien, TR; Yu, K; McGlynn, KA; Petrick, JL; Pinto, L; Chen, CJ ; Hildesheim, A; Pfeiffer, RM; Lee, MH; Yang, HI | Alimentary pharmacology & therapeutics 54(6), 833-842 | | | |
2010 | Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based long-term follow-up study | Liu, J; Yang, HI; Lee, MH; Lu, SN; Jen, CL; Wang, LY; You, SL; Iloeje, UH; Chen, CJ | Gastroenterology 139(2), 474-482 | | | |
2012 | Incidence and determinants of spontaneous seroclearance of HB e antigen and DNA in patients with chronic hepatitis B | Yang, HI; Hung, HL; Lee, MH; Liu, J; Jen, CL; Su, J; Wang, LY; Lu, SN; You, SL; Iloeje, UH; Chen, CJ; REVEAL-HBV Study Group | Clin Gastroenterol Hepatol 10(5), 527-534 | | | |
2016 | Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis | Yang, HI ; Tseng, TC; Liu, J; Lee, MH; Liu, CJ; Su, TH; Batrla-Utermann, R; Chan, HL; Kao, JH; Chen, CJ | Clinical gastroenterology and hepatology 14(3), 461-468.e2 | | | |
2021 | Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects | Onabajo, OO; Wang, F; Lee, MH; Florez-Vargas, O; Obajemu, A; Tanikawa, C; Vargas, JM; Liao, SF; Song, C; Huang, YH; Shen, CY ; Banday, AR; O'Brien, TR; Hu, Z; Matsuda, K; Prokunina-Olsson, L | Frontiers in immunology 12, 692263 | | | |
2019 | Level of hepatitis B (HB) core antibody associates with seroclearance of HBV DNA and HB surface antigen in HB e antigen-seronegative patients. | Hu, HH; Liu, J; Chang, CL; Jen, CL; Lee, MH; Lu, SN; Wang, LY; Quan, Y; Xia, NS; Chen, CJ ; Chen, PJ; Yang, HI | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 17(1), 172-172-181.e1 | | | |
2011 | Lifetime risk and gender difference of hepatocellular carcinoma among patients affected with chronic hepatitis B and C | Huang, YT; Jen, CL; Yang, HI; Lee, MH; Su, J; Lu, SN; Iloeje, UH; Chen, CJ; REVEAL-HBV/HCV Study Group | Journal of Clinical Oncology 29(27), 3643-3650 | | | |
2015 | Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk. | Huang, YT; Yang, HI; Liu, J; Lee, MH; Freeman, JR; Chen, CJ | EPIDEMIOLOGY 27(1), 14-20 | | | |
2016 | Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk. | Huang, YT; Yang, HI; Liu, J; Lee, MH; Freeman, JR; Chen, CJ | EPIDEMIOLOGY 27(1), 14-20 | | | |
2016 | Mediation effect of hepatitis B and C on mortality. | Huang, YT ; Freeman, JR; Yang, HI ; Liu, J; Lee, MH; Chen, CJ | European journal of epidemiology 31(6), 625-33 | | | |
2013 | Models predicting long-term risk of liver cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients: risk scores integrating characteristics of host and hepatitis B virus | Lee, MH; Yang, HI; Liu, J; Batrla-Utermann, R; Jen, CL; Iloeje, UH; Jun, J; Lu, SN; You, SL; Wang, LY; Chen, CJ; REVEAL-HBV Study Group | Hepatology | | | |
2005 | Molecular visualization of the yeast Dmc1 protein ring and Dmc1-ssDNA nucleoprotein complex. | Chang, YC; Lo, YH; Lee, MH; Leng, CH; Hu, SM; Chang, CS; Wang, TF | Biochemistry 44(16), 6052-6058 | | | |